Castrate-Resistant Prostate Cancer Market: In-Depth Analysis and Trends 2032
Castrate-Resistant Prostate Cancer (CRPC) is a critical area of focus within oncology due to its complex nature and the significant challenges it presents in treatment. CRPC occurs when prostate cancer progresses despite the suppression of androgenic hormones, which are typically responsible for the growth of prostate cancer cells. As of 2023, the Castrate-Resistant Prostate Cancer […]